// App-Quantinova.ai

: Beyond ABR: high fix activity translates into clinical benefits

Researchers

Presenter

  • G. Young

Principal Investigators

  • M. Carcao

  • S. Kearney

  • S. Seremetis

  • D. L. Cooper

Medical Centers

  • Hemostasis and Thrombosis Center, Children's Hospital Los Angeles, Los Angeles, CA, USA

  • Division of Haematology/Oncology, Department of Paediatrics and Research Institute, Hospital for Sick Children, University of Toronto, Toronto, ON, Canada

  • Children's Hospitals and Clinics of Minnesota Hemophilia and Thrombosis Center, Minneapolis, MN, USA

  • Novo Nordisk Inc., Plainsboro, NJ, USA

Locations

  • United States

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Randomized

  • Double Blind/Blinded

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • Baxter

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved